|
Originally published In Press as doi:10.1074/jbc.M301812200 on March 12, 2003
J. Biol. Chem., Vol. 278, Issue 20, 18022-18029, May 16, 2003
Glucocorticoids Inhibit Apoptosis during Fibrosarcoma Development
by Transcriptionally Activating Bcl-xL*
Duncan M.
Gascoyne §,
Robert M.
Kypta¶, and
Maria d. M.
Vivanco
From The Breakthrough Toby Robins Breast Cancer
Research Centre, Institute of Cancer Research, 237 Fulham Road, London
SW3 6JB and the ¶ Prostate Cancer Research Group, Department of
Cancer Medicine, Division of Medicine, Imperial College, Du Cane Road,
London W12 0NN, United Kingdom
Glucocorticoids influence many physiological
processes, and in particular apoptosis, often with opposite effects
depending on the cell type examined. We found that during fibrosarcoma
development there is a strong increase in apoptosis at the tumor stage,
which is repressed by dexamethasone to levels observed in normal
fibroblasts. The anti-apoptotic Bcl-2 family protein
Bcl-xL is induced by dexamethasone at the
transcriptional level at all stages of fibrosarcoma development. The
ligand-activated glucocorticoid receptor (GR) activates the Bcl-x
promoter in transient transfection experiments, and GR binds to
specific Bcl-x promoter sequences in vitro and in
vivo. Furthermore, a GR antagonist abolishes this effect,
indicating that Bcl-xL induction is mediated by GR.
Importantly, exogenous Bcl-xL inhibits apoptosis and
caspase-3 activity in fibrosarcoma cells to levels found in
dexamethasone-treated fibrosarcoma cells. We conclude that
Bcl-xL is a key target mediating the anti-apoptotic effects of glucocorticoids during fibrosarcoma development. These observations provide further understanding of the molecular basis of glucocorticoid regulation of cell death during tumorigenesis.
*
This work was supported by the Leopold Muller Trust and the
Institute of Cancer Research.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Present address: Medical Molecular Biology Unit, Institute of Child
Health, 30 Guilford St., London WC1N 1EH, United Kingdom.
To whom correspondence should be addressed. Tel.:
44-207-970-6001; Fax: 44-207-352-5241; E-mail: mariav@icr.ac.uk.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J.-M. Lee, P. Yan, Q. Xiao, S. Chen, K.-Y. Lee, C. Y. Hsu, and J. Xu
Methylprednisolone Protects Oligodendrocytes But Not Neurons after Spinal Cord Injury
J. Neurosci.,
March 19, 2008;
28(12):
3141 - 3149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Rocha-Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci
Glucocorticoids Repress bcl-X Expression in Lymphoid Cells by Recruiting STAT5B to the P4 Promoter
J. Biol. Chem.,
November 10, 2006;
281(45):
33959 - 33970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. B. Runnebaum and A. Bruning
Glucocorticoids Inhibit Cell Death in Ovarian Cancer and Up-regulate Caspase Inhibitor cIAP2
Clin. Cancer Res.,
September 1, 2005;
11(17):
6325 - 6332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Lee, D. Ndisang, C. Patel, J. H. Dennis, D. J. Faulkes, C. D'Arrigo, L. Samady, S. Farooqui-Kabir, R. J. Heads, D. S. Latchman, et al.
Expression of the Brn-3b Transcription Factor Correlates with Expression of HSP-27 in Breast Cancer Biopsies and Is Required for Maximal Activation of the HSP-27 Promoter
Cancer Res.,
April 15, 2005;
65(8):
3072 - 3080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Liao, S. Tang, J. B. Thrasher, T. L. Griebling, and B. Li
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
Mol. Cancer Ther.,
April 1, 2005;
4(4):
505 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Hudson, P. J. Morris, D. S. Latchman, and V. S. Budhram-Mahadeo
Brn-3a Transcription Factor Blocks p53-mediated Activation of Proapoptotic Target Genes Noxa and Bax in Vitro and in Vivo to Determine Cell Fate
J. Biol. Chem.,
March 25, 2005;
280(12):
11851 - 11858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Y. Almawi, O. K. Melemedjian, and M. M. A. Jaoude
On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis
J. Leukoc. Biol.,
July 1, 2004;
76(1):
7 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Viegas, G. P. Vicent, J. L. Baranao, M. Beato, and A. Pecci
Steroid Hormones Induce bcl-X Gene Expression through Direct Activation of Distal Promoter P4
J. Biol. Chem.,
March 12, 2004;
279(11):
9831 - 9839.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|